查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108338

蛋白質體學市場分析及預測（至2035年）：依類型、產品、服務、技術、組件、應用、流程、最終使用者、解決方案、模式分類

Proteomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球蛋白質體學市場預計將從2025年的291億美元成長到2035年的814億美元，CAGR為10.8%。精準醫療、生物標記發現和先進疾病研究的需求不斷成長是推動蛋白質體學市場發展的主要因素。據美國國立衛生研究院（NIH）表示，國家癌症實驗室的臨床蛋白質組學腫瘤分析聯盟（CPTAC）持續生成大規模蛋白質組學資料集，用於改進癌症診斷和治療策略。質譜、蛋白質序列測定和基於人工智慧（AI）的資料分析技術的進步加速其在腫瘤學、藥物研發和個人化醫療領域的應用，推動市場擴張。

蛋白質體學市場依類型可分為表達蛋白質體學、結構蛋白質體學和功能蛋白質體學。其中，表達蛋白質體學因其在識別和量化與疾病、藥物反應和生物過程相關的蛋白質表現模式方面的廣泛應用而佔據較大的市場佔有率。功能性蛋白質體學也呈現強勁成長動力，因為它能夠分析蛋白質的功能、相互作用和調控機制，推動藥物發現和生物標記鑑定的發展。結構蛋白質體學也日益受到重視，因為它能夠闡明蛋白質的3D結構，促進標靶治療和精準醫療方法的發展。

市場區隔
類型 表達蛋白質體學、結構蛋白質體學、功能蛋白質體學、其他
產品 設備、試劑、軟體、其他
服務 蛋白質體學評分服務、生物資訊解決方案、蛋白質鑑定、蛋白質分離、蛋白質定量、其他
技術 質譜分析、層析法、電泳分析、蛋白質微陣列分析、X光晶體結構分析、核磁共振波譜分析、其他
組件 蛋白質、胜肽、胺基酸、其他
用途 藥物研發、臨床診斷、生物技術、農業、其他
過程 樣品製備、分離、檢測、資料分析、其他
最終用戶 製藥公司、研究機構、生技公司、診斷檢驗實驗室、其他
解決方案 蛋白質體學資料分析、蛋白質表徵、生物標記發現、其他
模式 內部實施、外包、其他

蛋白質體學市場的應用領域包括藥物研發、臨床診斷、生物技術、農業等。藥物研發是其主要應用領域，這主要得益於蛋白質體學技術在標靶辨識、檢驗和新型療法開發方面的廣泛應用。臨床診斷領域也在不斷擴張，這主要歸功於基於蛋白質的生物標記在疾病早期檢測、個人化治療策略和疾病進展監測方面的應用日益廣泛。在生物技術領域，隨著蛋白質工程和分子研究的進步，蛋白質體學的應用也不斷成長。同時，在農業領域，蛋白質體學正用於作物改良、抗病性研究和提高農業生產力。生命科學研究投入的增加推動市場進一步成長。

區域概覽

到2025年，北美將佔據全球蛋白質組學市場最大佔有率，這主要得益於其先進的生命科學研究基礎設施、強大的生物技術和製藥公司網路以及對精準醫療的大量投資。蛋白質體學技術在該地區廣泛應用於生物標記發現、藥物研發、臨床診斷和個人化醫療。領先的學術機構、研究組織和政府機構持續增加對蛋白質分析、質譜和生物資訊平台的投入。此外，生物技術公司與研究機構之間合作的加強，以及對標靶治療和轉化研究日益成長的需求，將進一步鞏固北美在全球蛋白質體學市場的主導地位。

亞太地區預計將成為蛋白質體學市場成長最快的地區，這主要得益於生物技術和製藥行業的擴張、政府對體學研究投入的增加以及精準醫療的日益普及。中國、日本、印度、韓國和新加坡等國家正大力投資先進的蛋白質體學技術，包括質譜分析、蛋白質微陣列和高性能分析平台。癌症、感染疾病和神經系統疾病研究活動的活性化，以及臨床研究基礎設施的擴建，進一步推動了市場成長。此外，在政府支持措施和醫療保健支出不斷成長的推動下，學術機構、醫療機構和生物技術公司之間合作的加強，預計將使亞太地區在預測期內成為成長最快的區域市場。

主要趨勢和促進因素

人工智慧（AI）和多體學技術在蛋白質體學研究中的整合進展。

在蛋白質體學市場，人工智慧（AI）、機器學習和多組體學方法的融合已成為一種日益成長的趨勢，目的是增強蛋白質分析和生物學發現。先進的計算工具加速複雜蛋白質體學資料集的分析，改善生物標記的識別、疾病表徵和藥物發現。蛋白質體學與基因組學、轉錄組學和代謝體學的結合，有助於更全面地理解疾病機制和個人化醫療方法。此外，質譜、單細胞蛋白質體學和太空蛋白質體學技術的進步拓展腫瘤學、診斷學和藥物開發等領域的研究能力，推動整個蛋白質體學生態系統的創新。

對精準醫療和生物標記發現的需求日益成長

精準醫療的日益普及和對可靠生物標記日益成長的需求是蛋白質體學市場的主要驅動力。蛋白質體學分析使研究人員和臨床醫生能夠識別疾病特異性蛋白質特徵，輔助早期診斷、治療方案選擇和治療反應監測。癌症、神經系統疾病、心血管疾病和其他複雜疾病的日益普遍，推動了對先進診斷和研究工具的需求。此外，製藥和生物技術公司藥物發現、標靶檢驗和臨床開發中利用蛋白質體學技術。對生命科學研究的持續投入、政府主導的基因組學和蛋白質組學計劃以及分析平台的進步，都在進一步加速市場成長。

目錄

第1章 執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機會
  • 市場限制因素
  • 年複合成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 表達蛋白質體學
    • 結構蛋白質體學
    • 功能蛋白質體學
    • 其他
  • 市場規模及預測：依產品分類
    • 裝置
    • 試劑
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 蛋白質體學評分服務
    • 生物資訊解決方案
    • 蛋白質鑑定
    • 蛋白質分離
    • 蛋白質定量
    • 其他
  • 市場規模及預測：依技術分類
    • 質譜分析
    • 層析法
    • 電泳
    • 蛋白質微陣列
    • X光晶體結構分析
    • 核磁共振波譜
    • 其他
  • 市場規模及預測：依應用領域分類
    • 藥物發現
    • 臨床診斷
    • 生物技術
    • 農業
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 研究機構
    • 生技公司
    • 診斷檢測實驗室
    • 其他
  • 市場規模及預測：依組件分類
    • 蛋白質
    • 胜肽
    • 胺基酸
    • 其他
  • 市場規模及預測：依過程分類
    • 樣品製備
    • 分離
    • 偵測
    • 資料分析
    • 其他
  • 市場規模及預測：依解決方案分類
    • 蛋白質體學資料分析
    • 蛋白質表徵
    • 生物標記發現
    • 其他
  • 市場規模及預測：依模式
    • 內部實施
    • 外包
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要公司的策略

第8章 公司簡介

  • Thermo Fisher Scientific
  • Agilent Technologies
  • Danaher Corporation
  • Bruker Corporation
  • Waters Corporation
  • Bio-Rad Laboratories
  • PerkinElmer
  • Merck KGaA
  • Shimadzu Corporation
  • GE Healthcare
  • Illumina
  • Qiagen
  • SCIEX
  • Promega Corporation
  • Sartorius AG
  • Luminex Corporation
  • Horiba
  • Becton Dickinson and Company
  • Cell Signaling Technology
  • Abcam

第9章 關於我們

簡介目錄
Product Code: GIS20619

The global Proteomics Market is projected to grow from $29.1 billion in 2025 to $81.4 billion by 2035, at a compound annual growth rate (CAGR) of 10.8%. The proteomics market is driven by increasing demand for precision medicine, biomarker discovery, and advanced disease research. According to the National Institutes of Health (NIH), the National Cancer Institutes Clinical Proteomic Tumor Analysis Consortium (CPTAC) continues to generate large-scale proteomic datasets to improve cancer diagnosis and treatment strategies. Advancements in mass spectrometry, protein sequencing, and artificial intelligence-based data analysis are accelerating applications in oncology, drug discovery, and personalized healthcare, supporting market expansion.

The Type segment of the Proteomics Market includes expression proteomics, structural proteomics, functional proteomics, and others. Among these, expression proteomics holds a significant market share due to its widespread application in identifying and quantifying protein expression patterns associated with diseases, drug responses, and biological processes. Functional proteomics is witnessing strong growth as it enables the analysis of protein functions, interactions, and regulatory mechanisms, supporting advancements in drug discovery and biomarker identification. Structural proteomics is also gaining importance due to its role in understanding three-dimensional protein structures, facilitating the development of targeted therapies and precision medicine approaches.

Market Segmentation
TypeExpression Proteomics, Structural Proteomics, Functional Proteomics, Others
ProductInstruments, Reagents, Software, Others
ServicesCore Proteomics Services, Bioinformatics Solutions, Protein Identification, Protein Separation, Protein Quantification, Others
TechnologyMass Spectrometry, Chromatography, Electrophoresis, Protein Microarrays, X-ray Crystallography, NMR Spectroscopy, Others
ComponentProteins, Peptides, Amino Acids, Others
ApplicationDrug Discovery, Clinical Diagnostics, Biotechnology, Agriculture, Others
ProcessSample Preparation, Separation, Detection, Data Analysis, Others
End UserPharmaceutical Companies, Research Institutes, Biotechnology Companies, Diagnostic Laboratories, Others
SolutionsProteomics Data Analysis, Protein Characterization, Biomarker Discovery, Others
ModeIn-house, Outsourced, Others

The Application segment of the Proteomics Market includes drug discovery, clinical diagnostics, biotechnology, agriculture, and others. Drug discovery represents a major application area due to the increasing use of proteomics technologies for target identification, validation, and development of novel therapeutics. Clinical diagnostics is expanding with the growing adoption of protein-based biomarkers for early disease detection, personalized treatment strategies, and monitoring disease progression. Biotechnology applications are increasing due to advancements in protein engineering and molecular research, while agriculture is adopting proteomics for crop improvement, disease resistance studies, and enhanced agricultural productivity. Growing investments in life sciences research are further driving market growth.

Geographical Overview

North America accounted for the largest share of the global proteomics market in 2025, driven by its advanced life sciences research infrastructure, strong presence of biotechnology and pharmaceutical companies, and substantial investments in precision medicine. The region has witnessed widespread adoption of proteomics technologies in biomarker discovery, drug development, clinical diagnostics, and personalized healthcare. Leading academic institutions, research organizations, and government agencies continue to invest heavily in protein analysis, mass spectrometry, and bioinformatics platforms. Furthermore, increasing collaborations between biotechnology firms and research institutes, coupled with rising demand for targeted therapies and translational research, continue to strengthen North America's leadership in the global proteomics market.

Asia Pacific is expected to witness the highest growth in the proteomics market owing to expanding biotechnology and pharmaceutical industries, increasing government funding for omics research, and growing adoption of precision medicine. Countries such as China, Japan, India, South Korea, and Singapore are investing significantly in advanced proteomics technologies, including mass spectrometry, protein microarrays, and high-throughput analytical platforms. Rising research activities in cancer, infectious diseases, and neurological disorders, along with expanding clinical research infrastructure, are further fueling market growth. In addition, increasing collaborations between academic institutions, healthcare organizations, and biotechnology companies, supported by favorable government initiatives and growing healthcare expenditure, are expected to position Asia Pacific as the fastest-growing regional market during the forecast period.

Key Trends and Drivers

Increasing Integration of Artificial Intelligence and Multi-Omics Technologies in Proteomics Research:

The Proteomics Market is witnessing a growing trend toward the integration of artificial intelligence (AI), machine learning, and multi-omics approaches to enhance protein analysis and biological discovery. Advanced computational tools are enabling faster interpretation of complex proteomic datasets, improving biomarker identification, disease characterization, and drug target discovery. The combination of proteomics with genomics, transcriptomics, and metabolomics is supporting a more comprehensive understanding of disease mechanisms and personalized medicine approaches. Additionally, advancements in mass spectrometry, single-cell proteomics, and spatial proteomics technologies are expanding research capabilities across oncology, diagnostics, and pharmaceutical development, driving innovation throughout the proteomics ecosystem.

Rising Demand for Precision Medicine and Biomarker Discovery:

The increasing adoption of precision medicine and the growing need for reliable biomarkers are major drivers of the Proteomics Market. Proteomic analysis enables researchers and clinicians to identify disease-specific protein signatures that support early diagnosis, treatment selection, and monitoring of therapeutic responses. The rising prevalence of cancer, neurological disorders, cardiovascular diseases, and other complex conditions is increasing demand for advanced diagnostic and research tools. Furthermore, pharmaceutical and biotechnology companies are leveraging proteomics technologies for drug discovery, target validation, and clinical development. Continuous investments in life sciences research, government-funded genomics and proteomics initiatives, and advancements in analytical platforms are further accelerating market growth.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Expression Proteomics
    • 4.1.2 Structural Proteomics
    • 4.1.3 Functional Proteomics
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Reagents
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Core Proteomics Services
    • 4.3.2 Bioinformatics Solutions
    • 4.3.3 Protein Identification
    • 4.3.4 Protein Separation
    • 4.3.5 Protein Quantification
    • 4.3.6 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Mass Spectrometry
    • 4.4.2 Chromatography
    • 4.4.3 Electrophoresis
    • 4.4.4 Protein Microarrays
    • 4.4.5 X-ray Crystallography
    • 4.4.6 NMR Spectroscopy
    • 4.4.7 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Drug Discovery
    • 4.5.2 Clinical Diagnostics
    • 4.5.3 Biotechnology
    • 4.5.4 Agriculture
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Pharmaceutical Companies
    • 4.6.2 Research Institutes
    • 4.6.3 Biotechnology Companies
    • 4.6.4 Diagnostic Laboratories
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Proteins
    • 4.7.2 Peptides
    • 4.7.3 Amino Acids
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Preparation
    • 4.8.2 Separation
    • 4.8.3 Detection
    • 4.8.4 Data Analysis
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Proteomics Data Analysis
    • 4.9.2 Protein Characterization
    • 4.9.3 Biomarker Discovery
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 In-house
    • 4.10.2 Outsourced
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Thermo Fisher Scientific
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Agilent Technologies
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Danaher Corporation
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Bruker Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Waters Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bio-Rad Laboratories
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 PerkinElmer
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Merck KGaA
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Shimadzu Corporation
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 GE Healthcare
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Illumina
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Qiagen
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 SCIEX
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Promega Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Sartorius AG
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Luminex Corporation
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Horiba
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Becton Dickinson and Company
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Cell Signaling Technology
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Abcam
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us